Affiliation:
1. Pharmaceutical Department, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany
2. Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Martinistr 52, 20246 Hamburg, Germany
3. Federal Institute for Drugs and Medical Devices (BfArM), 53175 Bonn, Germany
Abstract
Heparan sulfate proteoglycans (HSPGs) possess various functions driving malignancy of tumors. However, their impact on tumor cell sensitivity to cytotoxic treatment is far less understood. Aiming to investigate this, we depleted HSPGs by downregulating Exostosin 1 (EXT1), a key enzyme in HS formation, or upregulating heparanase in human MV3 human melanoma cells, and investigated their response to cytotoxic drugs. Cytotoxicity of trametinib, doxorubicin, and mitoxantrone was detected by MTT assay. Insights into intracellular signaling was provided by kinome protein profiler array, and selected kinases were inhibited to investigate their impact on cell sensitization and migratory dynamics. EXT1 knockdown (EXT1kd) in MV3 cells affected the activity of doxorubicin and mitoxantrone, significantly increasing EC50 values two- or fourfold, respectively. Resistance formation was scarcely related to HSPG deficiency, suggested by enzymatic cleavage of HSPG in control cells. Notably, EXT1kd induced an upregulation of EGFR signaling via JNK and MEK/ERK, and hence blocking these kinases returned resistance to a sensitive level. JNK appeared as a key signal component, also inducing higher migratory activity of EXT1kd cells. Furthermore, EXT1kd upregulated thrombotic properties of MV3 cells, indicated by tissue factor and PAR-1 expression, functionally reflected by a stronger activation of platelet aggregation. EXT1 was confirmed to act as a tumor suppressor, shown here for the first time to affect chemosensitivity of melanoma cells.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference41 articles.
1. Tumor microenvironment complexity and therapeutic implications at a glance;Baghban;Cell Commun. Signal.,2020
2. Targeting Tumour-Associated Fibroblasts in Cancers;Shah;Front. Oncol.,2022
3. Environment-mediated drug resistance: A major contributor to minimal residual disease;Meads;Nat. Rev. Cancer,2009
4. β1-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transporters;Baltes;Biochim. Biophys. Acta Mol. Cell Res.,2020
5. Wantoch von Rekowski, K., König, P., Henze, S., Schlesinger, M., Zawierucha, P., Januchowski, R., and Bendas, G. (2019). The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells. Biomolecules, 9.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献